Kojic Acid

Kojic acid blocks tyrosinase, the enzyme that makes melanin, and fades melasma and dark spots about as well as hydroquinone in head-to-head studies. It is gentler than hydroquinone, and its fermentation origin is real, though origin is not what makes an ingredient safe.

The systemic safety concerns mostly do not survive a close look. Kojic acid causes thyroid and liver changes in rodents, but only at high oral doses, through a non-genotoxic mechanism that rodents are far more sensitive to than people, and it does not damage DNA. Applied to skin, less than 1% of the dose gets through. The US CIR panel and the EU safety committee both reviewed this and concluded it is safe as a skin-lightener at up to 1%, and Japan, where it has been used since the 1980s, reinstated it after a safety re-examination. It does not cause the skin staining, called ochronosis, that long-term hydroquinone can.

Two real things sit on top of the benefit. It can cause an allergic skin reaction in some people, and that reaction tends to build over months of daily use rather than appearing at once, so the risk grows with exposure even though the overall rate is low. And the amount in any given product is the variable that matters most. The EU caps kojic acid at 1% by law, the US sets no limit at all, and no label anywhere shows the percentage, so a European product is held to the strength regulators call safe while one sold elsewhere could be well above it with nothing to tell you.

That is why this depends on the product. A kojic acid serum from a maker that holds to the EU 1% limit, or that formulates responsibly, is a reasonable brightener for most people. An uncapped, high-strength one is more of a gamble, and the allergy risk is real enough that gentler options like azelaic acid or niacinamide reach the same goal for anyone whose skin reacts.